Close Menu

NEW YORK – NuProbe Global, a spinout from Harvard University's Wyss Institute, has merged with China's CarrierGene Biotech and has partnered with Illumina to develop clinical molecular diagnostic tests for genetic disorders.

The firm will continue to operate as NuProbe in the US and offer target enrichment assays for next-generation sequencing-based diagnostic tests based on toehold probes. Financial and other details of the merger were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.